Orthofix M6-C Disc in First U.S. Patients Following PMA

Orthofix Medical announced first commercial U.S. implants of the M6-C™ cervical disc following FDA Premarket Approval of the device, which occurred in 1Q19.

M6-C is designed to restore physiologic motion to the spine at the treated level, and features an artificial viscoelastic nucleus and fiber annulus that mimics the anatomic structure of a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us